Polymerase chain reaction (PCR) from paraffin-embedded tissues provides a powerful tool to amplify DNA from a variety of recent and archival material. Because DNA from paraffin-embedded samples is more degraded than from fresh material, the amplification of reference genes is essential to exclude falsenegative results. This study describes the use of the proliferative cell nuclear antigen (PCNA) gene as a reference gene in a range of animal species and in humans. The PCNA-PCR to amplify a fragment extending from exon 5 through exon 6 and including the intervening intron 6 gave a reproducible pattern, with a 280-base pair (bp) band from canine, equine, bovine, ovine, and caprine samples showing high sequence homology. Porcine, guinea pig, tiger, and lion samples, however, gave an additional fragment of approximately 197 bp. The whole intron 6 from these fragments is missing, possibly representing a pseudogene. In feline samples only the 197-bp fragment could be detected. This study shows that the PCNA gene is highly conserved across a broad range of animal species and is well suited as an internal control for PCR analysis in veterinary medicine.
The ability to amplify DNA from paraffin-embedded tissues (e.g., for the identification and specification of microorganisms) provides access to a large supply of recent and archival material from many sources. Small samples, such as biopsy samples, which would not normally be available as fresh tissue for DNA analysis, can often be obtained as paraffin-embedded samples. However, DNA in paraffin-embedded sections is more degraded than that in fresh material. Successful amplification of DNA from paraffin-embedded tissues is influenced by several additional factors, such as fixation time, type of fixative, size of the target (length of the DNA fragment to be amplified), and age of the paraffin blocks. Comparing several fixatives, 10% buffered neutral formalin and acetone were found to be best suited for subsequent polymerase chain reactions (PCRs). 6 For reverse transcriptase-polymerase chain reaction (RT-PCR), Omnifix II and Carnoy fixative were found to be better than formalin. 5 Although DNA products in the range of 400 base pair (bp) can be amplified from most sections, larger products may be amplified from only few samples. 11 Successful amplification from 40-yearold paraffin-embedded tissues has been reported. 6 However, DNA is known to degrade over time, 3 and the size of DNA fragments prepared from samples 4-6 years old is often reported to be smaller than the size of samples less than 2 years old. 8 The degree of DNA degradation and crosslinking can vary considerably between samples. This unpredictably influences the availability of DNA for PCR amplification, rendering the amplification of reference genes essential to avoid false-negative results. For this purpose, universally present and constitutively expressed genes, the so-called housekeeping genes, are used. PCR or RT-PCR of housekeeping genes, such as the beta-globin gene, 1 glyceraldehyde-3-phosphate dehydrogenase (GAPDH), or hypoxanthine phosphoribosyltransferase (HPRT) mRNA, 5 serves as a control for the presence of amplifiable DNA or RNA in tissues. In veterinary medicine, although a few conserved genes (beta-actin, cyclophilin, 4 HPRT, and GAPDH [8] [9] [10] ) are used for the housekeeping purpose, none of them has been investigated for a broad spectrum of both domestic and wild animals. As such, this gene should meet the criterion of being highly conserved throughout evolution.
In this article the use of the proliferative cell nuclear antigen (PCNA) gene as a reference gene in several animal species and human control is described. Sequences of PCNA in humans, a few animal species, yeast, and bacteria show that it is indeed evolutionarily conserved. The protein functions as a replication enzyme. It is a cofactor of DNA polymerase-delta, which is synthesized in the G 1 to S phase of cell division and the expression of which is closely related to cell proliferation. 2 This study shows that the PCNA gene is highly conserved across a broad range of animal species and is well suited as a reference gene for PCR analysis in veterinary medicine.
Freshly collected tissues originating from several animal species (dog, cat, horse, cattle, sheep, goat, pig, Table 1 . Primer sequences. The PCNA5 forward primer is complementary to the 5Ј-end of exon 5, whereas the PCNA6 reverse primer sits on the 3Ј-end of exon 6. (4), tiger (5), lion (6) , cat (7) , horse (8), cattle (9), sheep (10), goat (11) , and dog (12) samples. Molecular weight marker (1, 13) . guinea pig, tiger, and lion) were fixed in buffered 10% formalin for 18 hours and subsequently embedded in paraffin (1 skin and 1 skeletal muscle sample of each animal species, from the same animal). For this study, these tissues as well as formalin-fixed, paraffin-embedded archival tissues (up to 10 years old, with approximately 18 hours of fixation time) originating from humans and several animal species (dogs, cats, horses, cattle, sheep, goats, pigs, guinea pigs, tigers, and lions; 9 tissues of each species from different individual animals) were used. Ten tissues of each species (of different individual animals) originating from various organs (skin, skeletal muscle, lung, heart, stomach, intestine, liver, spleen, kidney, lymph node, uterus, thyroid gland, and brain) were analyzed. Thirty-micrometer sections were cut from each paraffin block and placed in a sterile microfuge tube. Paraffin was removed by extraction with 1.2 ml of xylene. After centrifugation at 13,000 ϫ g for 5 minutes, residual xylene was twice removed from the tissue pellet by adding 1.2 ml absolute ethanol. The sample was centrifuged (13,000 ϫ g, 5 minutes), and ethanol was carefully removed. Deoxyribonucleic acid was extracted from the tissue pellet with a commercial DNA extraction kit. a One microliter of each sample was used in the PCR. The primers (Table 1) , spanning from exon 5 to exon 6, were constructed according to the human PCNA gene sequence 13 (GenBank accession number J04718). The PCR was performed in 50-l reactions using 1.5 U Taq DNA polymerase, b 2.5 mM MgCl 2 , 200 M of each deoxynucleoside triphosphate, and 0.2 M of each primer. After 10 minutes of activation at 95 C, the cycle parameters were 40 cycles of 2 minutes at 94 C, 1 minute at 60 C, and 1 minute at 72 C. c The PCR fragments were analyzed by electrophoresis in a 1.5% Tris-acetate-ethylenediaminetetraacetic acid (EDTA) (40 mM Tris-base, 0.0114% acetic acid, 1 mM M EDTA) agarose gel. d The products were puri-fied using a gel extraction kit e and sequenced using standard sequencing procedures. f Sequences were analyzed using the GCG g program.
The PCNA-PCR of newly collected as well as archival formalin-fixed, paraffin-embedded tissues gave the expected 284-bp fragment in human samples (Fig.  1) . However, an additional 197-bp fragment was also amplified. Pig, guinea pig, tiger, and lion samples also gave rise to the approximately 284-and 197-bp bands. However, amplification of dog, horse, cattle, sheep, and goat samples resulted in only 1 larger fragment. In cat samples, only the smaller fragment could be detected.
The individual PCR products were purified and sequenced. Analysis of the sequences confirmed that exons 5 and 6 of the PCNA gene are indeed highly conserved in animals ( Fig. 2A, 2B) . In fact, the sequence homology of exons 5 and 6, excluding the intron, in both the larger and smaller fragments ranges from 78% to 99%. Not unexpectedly, the intron sequences vary more widely, ranging from 53% to 98% homology. Alignment of all the sequences revealed that the whole intron 6 is missing from the approximately 197-bp fragments. Other than the missing intron, these are almost identical to the normal PCNA gene structure (Fig.  2C) . This is an indication that PCNA pseudogenes may be present in the genome of these animals, although they remain to be experimentally confirmed.
The results show that with the primers used in this study it is possible to specifically amplify PCNA gene fragments from formalin-fixed, paraffin-embedded human and various mammalian samples. To exploit the conserved regions of the gene and amplify a fragment of approximately 280 bp, which can readily be extracted and sequenced from formalin-fixed tissues, the forward primer was designed to sit at the 5Ј-end of exon 5 and the reverse primer at the 3Ј-end of exon 6. The inclusion of an intron, with its inherent greater sequence variability, in the final product has the added advantage of permitting species identification after sequencing ( Fig. 2A) . Such an application can easily be extended to forensic identification of species as well. The presence of a putative pseudogene, with intron 6 omitted, in different species of animals suggests that this PCNA pseudogene may appear more frequently than expected across the species barriers. In fact, a PCNA pseudogene harboring other deletions has also been identified in human, 12 carrot, 7 and mouse. 14 However, deletion of intron 6 has not been reported in any species. These pseudogenes are probably the result of misintegration of the reverse-transcribed complementary DNA of the normal PCNA into the genome.
Curiously in cat, this was the only product detected, indicating that this gene may well be transcribed in this species. Whether this will also be the case for other species with both products remains to be determined. Although the role for the putative pseudogene is unknown, it is a useful element of this assay, revealing a characteristic species pattern in PCR ( Fig.  1) . Although the only certain way of confirming the identity of a PCR product is sequencing, running a PCR with, for instance, human, sheep, and cat DNA as controls, would give the full pattern and provide confidence that one is indeed amplifying the PCNA gene(s).
In summary, the PCNA gene is, as expected, evolutionarily conserved across different animal species. Thus, it may serve as a useful reference gene for the presence of amplifiable DNA in fresh and especially formalin-fixed, paraffin-embedded tissues from a wide range of animal species.
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